Dolby Laboratories $DLB Shares Acquired by Tredje AP fonden

Tredje AP fonden lifted its position in shares of Dolby Laboratories (NYSE:DLB) by 39.1% during the second quarter, Holdings Channel.com reports. The firm owned 12,764 shares of the electronics maker’s stock after acquiring an additional 3,589 shares during the period. Tredje AP fonden’s holdings in Dolby Laboratories were worth $948,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. MAI Capital Management grew its stake in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares during the period. Cheviot Value Management LLC acquired a new stake in Dolby Laboratories in the 1st quarter valued at $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in Dolby Laboratories in the 1st quarter valued at $29,000. Ameritas Advisory Services LLC acquired a new stake in Dolby Laboratories in the 2nd quarter valued at $48,000. Finally, UMB Bank n.a. grew its stake in Dolby Laboratories by 38.1% in the 2nd quarter. UMB Bank n.a. now owns 964 shares of the electronics maker’s stock valued at $72,000 after acquiring an additional 266 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Stock Up 0.1%

Shares of DLB opened at $66.36 on Tuesday. Dolby Laboratories has a 52-week low of $64.50 and a 52-week high of $89.66. The firm’s fifty day moving average is $70.47 and its two-hundred day moving average is $73.23. The stock has a market cap of $6.36 billion, a PE ratio of 24.31 and a beta of 0.92.

Analyst Upgrades and Downgrades

DLB has been the topic of a number of research analyst reports. Tigress Financial lifted their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, September 12th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Finally, Robert W. Baird started coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target on the stock. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.75.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the sale, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. The trade was a 17.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 82,000 shares of company stock worth $5,845,440. 38.39% of the stock is currently owned by corporate insiders.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.